DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Schramm TK, Gislason GH, Vaag A et al.
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
Eur Heart J 2011;
32 (15) 1900-1908
http://www.ncbi.nlm.nih.gov/pubmed/21471135
We do not assume any responsibility for the contents of the web pages of other providers.